Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ImmunGene Inc.
DescriptionMAb directed towards AML target attached to IFN through stable peptide linker system
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today